Ramsiya I. Malievskaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ramsiya I. Malievskaya has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Oleg A. Malievskiy
Bashkir State Medical University
8 shared publications - Diana Shamilevna Avzaletdinova
Bashkir State Medical University
4 shared publications Bashkir State Medical University
2 shared publications- I. G. Nasretdinova
City Clinical Hospital № 21
2 shared publications - Olga V. Kochetova
Institute of Biochemistry and Genetics, Ufa Federal Research Centre, Russian Academy of Sciences, 450054 Ufa, Russia
2 shared publications - Tat'Yana Vyacheslavovna Morugova
Bashkir State Medical University
2 shared publications
Latest Publications
- Open Access
- 18 January 2026
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 71 (6) , 97-101
Hypogonadotropic hypogonadism due to pathogenic variants in the POLR3B gene
Congenital hypogonadotropic hypogonadism (СНH) is a group of diseases caused by impaired synthesis or secretion of gonadotropin-releasing hormone (GnRH) and gonadotropin hormones. At present, more than twenty genes involved in the development of СНН have been described. In the structure of HGH, the most common forms of the disease are caused by pathogenic variants in genes involved in the ontogenesis, migration and survival of GnRH neurons, whereas pathology of genes involved in the action/transmission of GnRH signals in normally developed GnRH neurons is less common. This article describes a rare variant of СНН as a result of pathogenic variants in the POLR3B gene, occurring in 1.1% of cases of СНН, which is a component of hypomyelinating leukodystrophy 4H and includes hypomyelination, CHН, hypodontia. Identification of the genetic nature of the disease in this patient made it possible not only to establish the cause of CНН, but also to diagnose comorbid conditions.
- 18 January 2026
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 71 (6) , 97-101
Open AccessHypogonadotropic hypogonadism due to pathogenic variants in the POLR3B gene
Congenital hypogonadotropic hypogonadism (СНH) is a group of diseases caused by impaired synthesis or secretion of gonadotropin-releasing hormone (GnRH) and gonadotropin hormones. At present, more than twenty genes involved in the development of СНН have been described. In the structure of HGH, the most common forms of the disease are caused by pathogenic variants in genes involved in the ontogenesis, migration and survival of GnRH neurons, whereas pathology of genes involved in the action/transmission of GnRH signals in normally developed GnRH neurons is less common. This article describes a rare variant of СНН as a result of pathogenic variants in the POLR3B gene, occurring in 1.1% of cases of СНН, which is a component of hypomyelinating leukodystrophy 4H and includes hypomyelination, CHН, hypodontia. Identification of the genetic nature of the disease in this patient made it possible not only to establish the cause of CНН, but also to diagnose comorbid conditions.
- Open Access
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
A Multifactorial Model for Predicting Insulin Resistance in Patients with Type 1 Diabetes Mellitus
Aim. To develop a multivariate model for predicting insulin resistance in male and female patients with type 1 diabetes mellitus (T1DM). Design. Cross-sectional study. Materials and methods. The study included 317 adult patients (156 men and 161 women). The median age was 29 years; the median duration of T1DM was 13 years; the median body mass index (BMI) was 22.5 kg/m2; and the median glycated haemoglobin (HbA1c) was 9.4%. Physical inactivity was observed in 32 (10.1%) subjects; arterial hypertension was reported in 68 (21.5%) patients; and 86 (27.1%) patients were overweight. Anamnestic, anthropometric, and laboratory methods were used. Insulin resistance was diagnosed at an estimated insulin sensitivity of ≤ 5.02 mg/kg/min in men and ≤ 5.64 mg/kg/min in women, determined using the equation of D. Dabelea et al. (2011). To assess the association between qualitative attributes, the odds ratio with a 95% confidence interval was calculated. The null hypothesis was rejected at p < 0.05. ROC analysis was performed to identify the threshold levels of indicators, and their sensitivity and specificity were calculated. Wald’s sequential analysis was used to develop models for predicting insulin resistance. Results. The multivariate model for predicting insulin resistance in male patients included the following risk factors: age over 33 years; T1DM duration of over 19 years; BMI of 30 kg/m2 and above; waist circumference of over 84.5 cm; physical inactivity; total cholesterol > 4.87 mmol/L; low-density lipoprotein cholesterol > 3.22 mmol/L; triglycerides > 1.29 mmol/L; HbA1c > 9.4%; and the PIK3R1 gene rs3730089 AC genotype. In women, the model included: age over 37 years; T1DM duration of over 20 years; BMI of 30 kg/m2 and above; waist circumference of over 78 cm; physical inactivity; a family history of type 2 diabetes mellitus and overweight; total cholesterol > 4.80 mmol/L; low-density lipoprotein cholesterol > 2.83 mmol/L; triglycerides > 1.22 mmol/L; HbA1c > 9.9%; and the PIK3R1 gene rs3730089 AC genotype. Conclusion. This multivariate model allows for the prediction of insulin resistance in male and female patients with T1DM using readily available clinical and laboratory indicators. Keywords: type 1 diabetes mellitus, insulin resistance, risk factors
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
Open AccessA Multifactorial Model for Predicting Insulin Resistance in Patients with Type 1 Diabetes Mellitus
Aim. To develop a multivariate model for predicting insulin resistance in male and female patients with type 1 diabetes mellitus (T1DM). Design. Cross-sectional study. Materials and methods. The study included 317 adult patients (156 men and 161 women). The median age was 29 years; the median duration of T1DM was 13 years; the median body mass index (BMI) was 22.5 kg/m2; and the median glycated haemoglobin (HbA1c) was 9.4%. Physical inactivity was observed in 32 (10.1%) subjects; arterial hypertension was reported in 68 (21.5%) patients; and 86 (27.1%) patients were overweight. Anamnestic, anthropometric, and laboratory methods were used. Insulin resistance was diagnosed at an estimated insulin sensitivity of ≤ 5.02 mg/kg/min in men and ≤ 5.64 mg/kg/min in women, determined using the equation of D. Dabelea et al. (2011). To assess the association between qualitative attributes, the odds ratio with a 95% confidence interval was calculated. The null hypothesis was rejected at p < 0.05. ROC analysis was performed to identify the threshold levels of indicators, and their sensitivity and specificity were calculated. Wald’s sequential analysis was used to develop models for predicting insulin resistance. Results. The multivariate model for predicting insulin resistance in male patients included the following risk factors: age over 33 years; T1DM duration of over 19 years; BMI of 30 kg/m2 and above; waist circumference of over 84.5 cm; physical inactivity; total cholesterol > 4.87 mmol/L; low-density lipoprotein cholesterol > 3.22 mmol/L; triglycerides > 1.29 mmol/L; HbA1c > 9.4%; and the PIK3R1 gene rs3730089 AC genotype. In women, the model included: age over 37 years; T1DM duration of over 20 years; BMI of 30 kg/m2 and above; waist circumference of over 78 cm; physical inactivity; a family history of type 2 diabetes mellitus and overweight; total cholesterol > 4.80 mmol/L; low-density lipoprotein cholesterol > 2.83 mmol/L; triglycerides > 1.22 mmol/L; HbA1c > 9.9%; and the PIK3R1 gene rs3730089 AC genotype. Conclusion. This multivariate model allows for the prediction of insulin resistance in male and female patients with T1DM using readily available clinical and laboratory indicators. Keywords: type 1 diabetes mellitus, insulin resistance, risk factors
- 5 August 2025
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 106 (4) , 517-525
Features of type 1 diabetes mellitus in adults depending on the presence of insulin resistance
BACKGROUND: Insulin resistance contributes to the clinical course of type 1 diabetes mellitus and increases complication risk in adults. AIM: This study aimed to assess the clinical characteristics of type 1 diabetes mellitus and prevalence of its complications among men and women with and without insulin resistance. METHODS: Overall, 317 adults with type 1 diabetes mellitus were examined. The participants were divided into two groups: group 1, 81 patients with insulin resistance; and group 2, 236 patients without insulin resistance. Lipid metabolism parameters and prevalence of macrovascular and microvascular complications were assessed in each group. Anthropometric and laboratory studies included serum creatinine levels with subsequent estimation of glomerular filtration rate, total cholesterol, high- and low-density lipoproteins, triglycerides, and urinary albumin excretion in a random sample. Instrumental examinations involved electroneuromyography, duplex ultrasound scanning of the lower-limb arteries, and fundus examination. Insulin resistance was defined as an estimated insulin sensitivity ≤5.02 in men and ≤5.64 in women. Quantitative data with non-normal distribution were presented as median and 95% confidence interval. For normally distributed variables, the mean and standard deviation were calculated. Categorical data were presented as absolute and relative frequencies. Differences in quantitative parameters were assessed using the Mann–Whitney U test and differences in categorical indicators using the χ2 test. P 0.05 indicated significant differences. RESULTS: Insulin resistance prevalence among all patients was 25.6%. Compared to patients without insulin resistance, men and women with insulin resistance more frequently had overweight or obesity (men: 57.1% vs 12.3%, p 0.001; women: 56.4% vs 21.3%, p 0.001), higher total cholesterol levels (men: 5.3 vs 4.6 mmol/L, p 0.001; women: 5.6 vs 4.7 mmol/L, p 0.001), and increased low-density lipoprotein levels (men: 3.4 vs 2.8 mmol/L, p 0.001; women: 3.2 vs 2.7 mmol/L, p 0.001). Men with insulin resistance were more likely to experience hypertension (47.6% vs 14.9%, p 0.001), atherosclerosis (38.1% vs 14.9%, p = 0.004), diabetic nephropathy (54.8% vs 18.4%, p 0.001), and retinopathy (81.0% vs 56.1%, p = 0.008). Hypertension (46.1% vs 13.9%, p 0.001) and atherosclerosis (30.8% vs 11.5%, p = 0.010) were more prevalent in women with insulin resistance. CONCLUSION: The clinical course of type 1 diabetes mellitus in patients with insulin resistance is characterized by increased cholesterol and low-density lipoprotein levels, higher prevalence of overweight or obesity, and greater incidence of macrovascular complications compared to patients without insulin resistance.
- 5 August 2025
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 106 (4) , 517-525
Features of type 1 diabetes mellitus in adults depending on the presence of insulin resistance
BACKGROUND: Insulin resistance contributes to the clinical course of type 1 diabetes mellitus and increases complication risk in adults. AIM: This study aimed to assess the clinical characteristics of type 1 diabetes mellitus and prevalence of its complications among men and women with and without insulin resistance. METHODS: Overall, 317 adults with type 1 diabetes mellitus were examined. The participants were divided into two groups: group 1, 81 patients with insulin resistance; and group 2, 236 patients without insulin resistance. Lipid metabolism parameters and prevalence of macrovascular and microvascular complications were assessed in each group. Anthropometric and laboratory studies included serum creatinine levels with subsequent estimation of glomerular filtration rate, total cholesterol, high- and low-density lipoproteins, triglycerides, and urinary albumin excretion in a random sample. Instrumental examinations involved electroneuromyography, duplex ultrasound scanning of the lower-limb arteries, and fundus examination. Insulin resistance was defined as an estimated insulin sensitivity ≤5.02 in men and ≤5.64 in women. Quantitative data with non-normal distribution were presented as median and 95% confidence interval. For normally distributed variables, the mean and standard deviation were calculated. Categorical data were presented as absolute and relative frequencies. Differences in quantitative parameters were assessed using the Mann–Whitney U test and differences in categorical indicators using the χ2 test. P 0.05 indicated significant differences. RESULTS: Insulin resistance prevalence among all patients was 25.6%. Compared to patients without insulin resistance, men and women with insulin resistance more frequently had overweight or obesity (men: 57.1% vs 12.3%, p 0.001; women: 56.4% vs 21.3%, p 0.001), higher total cholesterol levels (men: 5.3 vs 4.6 mmol/L, p 0.001; women: 5.6 vs 4.7 mmol/L, p 0.001), and increased low-density lipoprotein levels (men: 3.4 vs 2.8 mmol/L, p 0.001; women: 3.2 vs 2.7 mmol/L, p 0.001). Men with insulin resistance were more likely to experience hypertension (47.6% vs 14.9%, p 0.001), atherosclerosis (38.1% vs 14.9%, p = 0.004), diabetic nephropathy (54.8% vs 18.4%, p 0.001), and retinopathy (81.0% vs 56.1%, p = 0.008). Hypertension (46.1% vs 13.9%, p 0.001) and atherosclerosis (30.8% vs 11.5%, p = 0.010) were more prevalent in women with insulin resistance. CONCLUSION: The clinical course of type 1 diabetes mellitus in patients with insulin resistance is characterized by increased cholesterol and low-density lipoprotein levels, higher prevalence of overweight or obesity, and greater incidence of macrovascular complications compared to patients without insulin resistance.
- Open Access
- 24 July 2025
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 28 (3) , 214-222
Prevalence of insulin resistance based on the estimated rate of glucose utilization among adult patients with type 1 diabetes and its role in predicting diabetic complications
BACKGROUND: The significance of determining insulin resistance (IR) in people with type 1 diabetes mellitus (T1DM) is determined by the acceleration of the transition from the first stage of development of T1DM to the second and third, and is also a risk factor for the development of chronic complications of diabetes. The lack of a unified criterion for determining metabolically significant insulin resistance in patients with T1DM determines the need to study this problem.AIM: To study the incidence of insulin resistance in individuals with T1DM over 18 years of age and disease duration of more than 1 year based on the estimated rate of glucose utilization and to determine the association between the eGDR value MATERIALS AND METHODS: 201 patients with T1DM over 18 years of age and T1DM duration of more than 1 year were examined. Among them, 95 (47%) were men, 106 (53%) were women. Median age was 30.0 [28.1; 33.0] years, median duration of T1DM — 13 [12; 15] years. The estimated rate of glucose utilization was estimated using the equation of Williams K. et al. (2000). Patients with an eGDR value RESULTS: The value of eGDR CONCLUSION: The fairly high prevalence of IR among patients with type 1 diabetes, the risk of developing diabetic nephropathy and atherosclerosis of the arteries of the lower extremities in these individuals, justifies the need to identify this condition in clinical practice in order to improve the course of type 1 diabetes.
- 24 July 2025
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 28 (3) , 214-222
Open AccessPrevalence of insulin resistance based on the estimated rate of glucose utilization among adult patients with type 1 diabetes and its role in predicting diabetic complications
BACKGROUND: The significance of determining insulin resistance (IR) in people with type 1 diabetes mellitus (T1DM) is determined by the acceleration of the transition from the first stage of development of T1DM to the second and third, and is also a risk factor for the development of chronic complications of diabetes. The lack of a unified criterion for determining metabolically significant insulin resistance in patients with T1DM determines the need to study this problem.AIM: To study the incidence of insulin resistance in individuals with T1DM over 18 years of age and disease duration of more than 1 year based on the estimated rate of glucose utilization and to determine the association between the eGDR value MATERIALS AND METHODS: 201 patients with T1DM over 18 years of age and T1DM duration of more than 1 year were examined. Among them, 95 (47%) were men, 106 (53%) were women. Median age was 30.0 [28.1; 33.0] years, median duration of T1DM — 13 [12; 15] years. The estimated rate of glucose utilization was estimated using the equation of Williams K. et al. (2000). Patients with an eGDR value RESULTS: The value of eGDR CONCLUSION: The fairly high prevalence of IR among patients with type 1 diabetes, the risk of developing diabetic nephropathy and atherosclerosis of the arteries of the lower extremities in these individuals, justifies the need to identify this condition in clinical practice in order to improve the course of type 1 diabetes.
- Open Access
- 16 May 2025
- Published by Focus Endocrinology in FOCUS. Endocrinology
- Vol. 6 (1) , 6-12
Metabolic syndrome in type 1 diabetes mellitus in adults
Background. The prevalence of metabolic syndrome (MS) among people with type 1 diabetes mellitus (T1DM) varies widely depending on the criteria used and ranges from 6.4 to 57%. The relevance of studying the MS in T1DM is caused by the high risk of developing of micro and macrovascular complications. The current criteria for MS and the controversy over the inclusion of T1DM as a criterion do not provide reliability in diagnosing MS in this disease.The aim. To assess the prevalence of MS in adults with T1DM and its impact on the course of the disease.Materials and methods. A total of 134 patients over the age of 18 years were studied, including 67 (50%) men and 67 (50%) women. The median age was 33[19; 43] years, the median duration of diabetes was 13 [4; 27] years. MS was assessed according to the criteria of the 2009 Joint Interim Statement (JIS).Results. MS was detected in 34 (25.4%) patients. The number of patients who did not have other criteria for MS except for T1DM was 57 (42.5%), 43 (32.1%) patients had 2 components of MS (one of the components in all was diabetes). Waist circumference >94 cm in men and > 80 cm in women, as well as blood pressure > 130 and 85 mm Hg were the most common components of MS (73.5 and 70.6% respectively). The insulin sensitivity coefficient was significantly lower in the group of people with MS (p=0.012). In patients with MS, only diabetic nephropathy was significantly more common (p = 0.019), while the differences in the frequency of retinopathy and neuropathy were statistically insignificant.Conclusion. MS is a common condition in T1DM, which is based on insulin resistance. Presence of MS is associated with a risk of developing of diabetic nephropathy.
- 16 May 2025
- Published by Focus Endocrinology in FOCUS. Endocrinology
- Vol. 6 (1) , 6-12
Open AccessMetabolic syndrome in type 1 diabetes mellitus in adults
Background. The prevalence of metabolic syndrome (MS) among people with type 1 diabetes mellitus (T1DM) varies widely depending on the criteria used and ranges from 6.4 to 57%. The relevance of studying the MS in T1DM is caused by the high risk of developing of micro and macrovascular complications. The current criteria for MS and the controversy over the inclusion of T1DM as a criterion do not provide reliability in diagnosing MS in this disease.The aim. To assess the prevalence of MS in adults with T1DM and its impact on the course of the disease.Materials and methods. A total of 134 patients over the age of 18 years were studied, including 67 (50%) men and 67 (50%) women. The median age was 33[19; 43] years, the median duration of diabetes was 13 [4; 27] years. MS was assessed according to the criteria of the 2009 Joint Interim Statement (JIS).Results. MS was detected in 34 (25.4%) patients. The number of patients who did not have other criteria for MS except for T1DM was 57 (42.5%), 43 (32.1%) patients had 2 components of MS (one of the components in all was diabetes). Waist circumference >94 cm in men and > 80 cm in women, as well as blood pressure > 130 and 85 mm Hg were the most common components of MS (73.5 and 70.6% respectively). The insulin sensitivity coefficient was significantly lower in the group of people with MS (p=0.012). In patients with MS, only diabetic nephropathy was significantly more common (p = 0.019), while the differences in the frequency of retinopathy and neuropathy were statistically insignificant.Conclusion. MS is a common condition in T1DM, which is based on insulin resistance. Presence of MS is associated with a risk of developing of diabetic nephropathy.
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Endocrinology: News, Opinions, Training
- Vol. 14 (2)
Search for genetic markers of insulin resistance in type 1 diabetes mellitus
Поиск генетических маркеров инсулинорезистентности при сахарном диабете 1 типа
- 1 January 2025
- Published by Geotar-Media Publishing Group in Endocrinology: News, Opinions, Training
- Vol. 14 (2)
Open AccessSearch for genetic markers of insulin resistance in type 1 diabetes mellitus
Поиск генетических маркеров инсулинорезистентности при сахарном диабете 1 типа
- Open Access
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
Association of the rs3730089 Nucleotide Sequence of the PIK3R1 Gene with Dyslipidemia in Type 1 Diabetes Mellitus
Aim. To analyze the association of the rs3730089 nucleotide sequence variant of the PIK3R1 gene with various metabolic disorders in patients with type 1 diabetes mellitus (T1DM). Design. A one-stage cross-sectional study. Materials and methods. 147 unrelated patients with T1DM were examined. Their height, body weight, waist and hip circumferences, and body mass index were measured. Laboratory tests included the determination of total cholesterol, high- and low-density lipoprotein cholesterol, and triglycerides. The variant of the nucleotide sequence was investigated using a polymerase chain reaction. Using the χ2 criterion, the correspondence of the frequency of genotypes to the Hardy — Weinberg equilibrium was estimated. The association of genotypes with insulin resistance was analyzed using the online SNPStats program. Association analysis is presented in codominant, dominant, recessive, overdominant, and additive models, as well as during the allele test. Results. The distribution of genotypes and alleles of the rs3730089 nucleotide sequence variant of the PIK3R1 gene in all patients corresponded to the Hardy — Weinberg equilibrium. There was a significant association of A/C and A/A genotypes in dominant models with elevated levels of low-density lipoproteins and cholesterol. In the overdominant model, the association of the A/C genotype with elevated triglyceride levels, as well as with increased waist circumference and overweight in patients with Т1DM was determined (odds ratio — 10.5, 95% confidence interval: 3.94–27.99, p < 0.0001, рFDR = 0.0001 and odds ratio — 5.70, 95% confidence interval: 2.28–14.26, p = 0.0001, рFDR = 0.0002, respectively). For all of the above indicators, allele A was risky. Associations of genotypes and alleles of the rs3730089 nucleotide sequence variant of the PIK3R1 gene with a reduced level of high-density lipoproteins have not been found. Conclusion. The nucleotide sequence rs3730089 of the PIK3R1 gene is associated with lipid metabolism disorders in patients with Т1DM. Allele A is risky. This variant of the nucleotide sequence may be associated with insulin resistance in people with T1DM. Keywords: type 1 diabetes mellitus, PIK3R1 gene, nucleotide sequence rs3730089, dyslipidemia.
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
Open AccessAssociation of the rs3730089 Nucleotide Sequence of the PIK3R1 Gene with Dyslipidemia in Type 1 Diabetes Mellitus
Aim. To analyze the association of the rs3730089 nucleotide sequence variant of the PIK3R1 gene with various metabolic disorders in patients with type 1 diabetes mellitus (T1DM). Design. A one-stage cross-sectional study. Materials and methods. 147 unrelated patients with T1DM were examined. Their height, body weight, waist and hip circumferences, and body mass index were measured. Laboratory tests included the determination of total cholesterol, high- and low-density lipoprotein cholesterol, and triglycerides. The variant of the nucleotide sequence was investigated using a polymerase chain reaction. Using the χ2 criterion, the correspondence of the frequency of genotypes to the Hardy — Weinberg equilibrium was estimated. The association of genotypes with insulin resistance was analyzed using the online SNPStats program. Association analysis is presented in codominant, dominant, recessive, overdominant, and additive models, as well as during the allele test. Results. The distribution of genotypes and alleles of the rs3730089 nucleotide sequence variant of the PIK3R1 gene in all patients corresponded to the Hardy — Weinberg equilibrium. There was a significant association of A/C and A/A genotypes in dominant models with elevated levels of low-density lipoproteins and cholesterol. In the overdominant model, the association of the A/C genotype with elevated triglyceride levels, as well as with increased waist circumference and overweight in patients with Т1DM was determined (odds ratio — 10.5, 95% confidence interval: 3.94–27.99, p < 0.0001, рFDR = 0.0001 and odds ratio — 5.70, 95% confidence interval: 2.28–14.26, p = 0.0001, рFDR = 0.0002, respectively). For all of the above indicators, allele A was risky. Associations of genotypes and alleles of the rs3730089 nucleotide sequence variant of the PIK3R1 gene with a reduced level of high-density lipoproteins have not been found. Conclusion. The nucleotide sequence rs3730089 of the PIK3R1 gene is associated with lipid metabolism disorders in patients with Т1DM. Allele A is risky. This variant of the nucleotide sequence may be associated with insulin resistance in people with T1DM. Keywords: type 1 diabetes mellitus, PIK3R1 gene, nucleotide sequence rs3730089, dyslipidemia.
- Open Access
- 28 February 2024
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 70 (1) , 100-104
Preclinical diagnostics of von Hippel-Lindau syndrome in a child
The description of the child aged 5 months with the von Hippel-Lindau syndrome without any manifestations of this syndrome is presented. The reason for the molecular genetic examination was the presence of cases of this syndrome in the family (mother and sister). The heterozygous variant c.355T>C p.F119L was found in the VHL gene. An objective examination revealed no pathology. A comprehensive laboratory and instrumental examination aimed at searching for components of the von Hippel-Lindau syndrome, including a blood test for metanephrines and normetanephrines, ultrasound of the abdominal organs, examination of the fundus, also did not reveal any abnormalities. Given the results of molecular genetic diagnosis, the child remains under observation and will undergo regular examinations to identify components of the von Hippel-Lindau syndrome, including blood/urine tests for normetanephrines.
- 28 February 2024
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 70 (1) , 100-104
Open AccessPreclinical diagnostics of von Hippel-Lindau syndrome in a child
The description of the child aged 5 months with the von Hippel-Lindau syndrome without any manifestations of this syndrome is presented. The reason for the molecular genetic examination was the presence of cases of this syndrome in the family (mother and sister). The heterozygous variant c.355T>C p.F119L was found in the VHL gene. An objective examination revealed no pathology. A comprehensive laboratory and instrumental examination aimed at searching for components of the von Hippel-Lindau syndrome, including a blood test for metanephrines and normetanephrines, ultrasound of the abdominal organs, examination of the fundus, also did not reveal any abnormalities. Given the results of molecular genetic diagnosis, the child remains under observation and will undergo regular examinations to identify components of the von Hippel-Lindau syndrome, including blood/urine tests for normetanephrines.
- Open Access
- 1 January 2024
- Published by Focus Endocrinology in FOCUS. Endocrinology
- Vol. 5 (3) , 92-95
GCK-MODY: Clinical case report
Currently, monogenic forms of diabetes mellitus account for up to 6.5% of all cases of diabetes in children and adolescents. Among the 14 currently identified types of MODY diabetes, the most common are HNF4a-, GCK-, and HNF1a-MODY. Among the latter, GCK-MODY has the mildest course, often not requiring drug therapy, with a favorable prognosis in terms of micro- and macrovascular complications. The development of molecular genetics makes it possible to more accurately verify various types of diabetes mellitus, predict the course of the disease, determine treatment tactics, and conduct medical genetic counseling for families. The aim of the article: to present follow-up data from a family with GCK-MODY diabetes
- 1 January 2024
- Published by Focus Endocrinology in FOCUS. Endocrinology
- Vol. 5 (3) , 92-95
Open AccessGCK-MODY: Clinical case report
Currently, monogenic forms of diabetes mellitus account for up to 6.5% of all cases of diabetes in children and adolescents. Among the 14 currently identified types of MODY diabetes, the most common are HNF4a-, GCK-, and HNF1a-MODY. Among the latter, GCK-MODY has the mildest course, often not requiring drug therapy, with a favorable prognosis in terms of micro- and macrovascular complications. The development of molecular genetics makes it possible to more accurately verify various types of diabetes mellitus, predict the course of the disease, determine treatment tactics, and conduct medical genetic counseling for families. The aim of the article: to present follow-up data from a family with GCK-MODY diabetes